67259-53-4

3H-1,5-Benzodiazepine, 2-(4-chlorophenyl)-4-(methylthio)-

Methanimidic acid, N-(4-chloro-2-methylphenyl)-, ethyl ester

3H-1,2,4-Triazol-3-one,2-acetyl-4-[(2-furanylmethylene)amino]-2,4-dihydro-5-propyl-

2-[1-(3-bromo-phenyl)-1H-imidazol-4-yl]-benzooxazole

2-Propynoic acid, 3-(2-chloro-4-nitrophenyl)-, ethyl ester

1H-Indole, 3-[2-[3-(4-methylphenoxy)-1-piperidinyl]ethyl]-

3H-1,2,4-Triazol-3-one,2-ethyl-2,4-dihydro-4-[4-[4-(4-methoxyphenyl)-1-piperazinyl]phenyl]-

3-Furanmethanol, 5-(3-fluorophenyl)-2-methyl-

3H-1,2,4-Triazol-3-one,2-[(2-aminophenyl)methyl]-2,4-dihydro-4-phenyl-

2,5-Diazabicyclo[2.2.1]heptane,2-methyl-5-[[6-(2-oxazolyl)-1H-indazol-3-yl]carbonyl]-, (1S,4S)-

3H-1,2,4-Triazol-3-one,2-[2,4-dichloro-5-(1-ethynyl-1,3-dimethylbutoxy)phenyl]-4-(difluoromethyl)-2,4-dihydro-5-methyl-

3H-1,2,4-Triazol-3-one,4-[(2-furanylmethylene)amino]-2,4-dihydro-5-methyl-

N'-(1,2-dimethylpropylidene)thiophene-2-carbohydrazide

Formic acid, compd. with(1S,4S)-2-[[5-(difluoromethoxy)-1H-indazol-3-yl]carbonyl]-5-methyl-2,5-diazabicyclo[2.2.1]heptane (1:1)

3H-1,2,4-Triazol-3-one,2-[2,4-dichloro-5-[(1-methyl-3-butynyl)oxy]phenyl]-4-(difluoromethyl)-2,4-dihydro-5-methyl-

Methanimidic acid, cyano-, pentyl ester

L-Valine, N-(chloroacetyl)-, methyl ester

3H-1,2,4-Triazol-3-one,4-[(3R,6S)-6-[[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-3-(2-hydroxyethyl)-6-phenyl-3-piperidinyl]-2,4-dihydro-

3-Furancarboxylic acid, 4-(1-propenyl)-, methyl ester, (E)-

3-Furancarboxylic acid,5-[(dimethylamino)methylene]-4,5-dihydro-2-methyl-4-oxo-, ethyl ester

3-Furanmethanol, 2-methyl-5-(4-methylphenyl)-

3-Furancarboxylic acid,5-(1,1-dimethylethyl)tetrahydro-2,2-diphenyl-5-(2-propenyl)-, methylester, cis-

3H-1,2,4-Triazol-3-one,4-[[[4-(dimethylamino)phenyl]methylene]amino]-2,4-dihydro-5-[(4-methylphenyl)methyl]-

2-Pyrrolidinemethanol, 1-[2-(4-amino-2-methoxyphenoxy)ethyl]-, (2S)-

L-Valine, N-(4-methoxybenzoyl)-L-leucyl-L-isoleucylglycyl-L-lysyl-

3-Furanmethanol, 2-(ethoxymethyl)-5-[4-(trifluoromethyl)phenyl]-

L-Tryptophanamide,N-(7-amino-1-oxoheptyl)-O-(phenylmethyl)-L-seryl-4-chloro-D-phenylalanyl-L-arginyl-

L-Serinamide, L-alanyl-L-tyrosyl-N-butyl-

3-Furanheptanoic acid, tetrahydro-2,4-dioxo-

3H-1,2,4-Triazol-3-one,2-[(1R,2R)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-2,4-dihydro-4-[4-(phenylmethoxy)phenyl]-

3-Furancarboxylic acid, 4-ethenyltetrahydro-2-hydroxy-2,4-dimethyl-,ethyl ester, (4S)-

3H-1,2,4-Triazol-3-one,4-[[(4-chlorophenyl)methylene]amino]-2,4-dihydro-

3-Furancarboxylic acid,4-ethenyltetrahydro-2-hydroxy-4-methyl-2-(4-nitrophenyl)-, ethyl ester,(4S)-

3-Furancarboxylic acid, 4,5-dimethyl-2-(1-methylpropyl)-, ethyl ester

Methanimidic acid, 2-(2,4-dinitrophenyl)hydrazide

2,7-Nonadien-4-ol, 8-methyl-7-[(trimethylsilyl)oxy]-, acetate, (E)-

3-Furancarboxylic acid, 4,5-dihydro-5-(iodomethyl)-2,4-diphenyl-, ethylester, (4R,5R)-rel-

67259-53-4 msds

CAS No 67259-53-4 supplier

CASNo 67259-53-4 distributor

CAS # 67259-53-4 manufacturer

CAS Number 67259-53-4 safety

CAS RN 67259-53-4 wholesale

2026-10-16 Find 3H-1,5-Benzodiazepine, 2-(4-chlorophenyl)-4-(methylthio)-,CAS No.67259-53-4,Formula:C16H13ClN2S in ChemGloble